Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Zentalis Pharmaceuticals, Llc (ZNTL)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 84,924,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. Co. is developing a pipeline of product candidates with an initial focus on validated oncology targets. Co. has two primary product candidates: ZN-c3, an inhibitor of Wee1, a protein tyrosine kinase, and ZN-c5, an oral selective estrogen receptor degrader. Co.'s other clinical product candidates include ZN-d5, a selective inhibitor of B-cell lymphoma 2 and ZN-e4, an irreversible inhibitor of mutant epidermal growth factor receptor.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 22,000 22,000
Total Buy Value $0 $0 $219,391 $219,391
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 2 2
Total Shares Sold 3,356 32,218 59,396 362,029
Total Sell Value $42,353 $375,045 $932,862 $8,774,551
Total People Sold 1 5 8 8
Total Sell Transactions 1 7 11 35
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 240
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gallagher Cam President, Interim CFO   •       •      –    2024-05-31 4 AS $11.98 $114,972 D/D (9,597) 633,680     -
   Walker Luke Nathaniel Director   –       •      –    2024-05-24 4 A $0.00 $0 D/D 72,481 72,481     -
   Hausman Diane Chief Medical Officer   •       –      –    2024-05-09 4 S $12.62 $42,353 D/D (3,356) 373,876     -
   Vultaggio Vincent Principal Accounting OfficerOf   •       –      –    2024-04-05 3 IO $0.00 $0 D/D 0 35,458     -
   Gallagher Cam President   •       •      –    2024-02-12 4 AS $11.44 $13,419 D/D (1,173) 643,277     -
   Epperly Melissa B, Chief Financial Officer   •       –      –    2024-02-12 4 AS $11.44 $29,435 D/D (2,573) 451,449     -
   Gallagher Cam President   •       •      –    2024-02-02 4 AS $11.54 $133,310 D/D (11,552) 644,450     -
   Epperly Melissa B, Chief Financial Officer   •       –      –    2024-02-02 4 AS $11.54 $100,040 D/D (8,669) 454,022     -
   Lackner Mark Chief Scientific Officer   •       –      –    2024-02-02 4 S $11.54 $18,291 D/D (1,585) 195,728     -
   Paul Andrea Chief Legal Officer   •       –      –    2024-02-02 4 S $11.54 $38,197 D/D (3,310) 149,973     -
   Blackwell Kimberly Chief Executive Officer   •       •      –    2024-02-01 4 D $11.69 $241,457 D/D (20,655) 484,145     -
   Blackwell Kimberly Chief Executive Officer   •       •      –    2024-02-01 4 A $0.00 $0 D/D 250,000 504,800     -
   Gallagher Cam President   •       •      –    2024-02-01 4 A $0.00 $0 D/D 192,500 656,002     -
   Epperly Melissa B, Chief Financial Officer   •       –      –    2024-02-01 4 A $0.00 $0 D/D 75,000 462,691     -
   Lackner Mark Chief Scientific Officer   •       –      –    2024-02-01 4 A $0.00 $0 D/D 141,000 197,313     -
   Hausman Diane Chief Medical Officer   •       –      –    2024-02-01 4 A $0.00 $0 D/D 337,500 377,232     -
   Paul Andrea Chief Legal Officer   •       –      –    2024-02-01 4 A $0.00 $0 D/D 112,500 153,283     -
   Lackner Mark Chief Scientific Officer   •       –      –    2024-01-02 4 A $0.00 $0 D/D 40,000 56,313     -
   Lackner Mark Chief Scientific OfficerOffice   •       –      –    2023-12-31 3 IO $0.00 $0 D/D 0 16,313     -
   Bunker Kevin D. Chief Scientific Officer   •       –      –    2023-12-20 4 GD $0.00 $0 D/D 24,158 834,931     -
   Blackwell Kimberly Chief Executive Officer   •       •      –    2023-11-13 4 B $10.29 $51,448 D/D 5,000 254,800 2.81     -
   Johnson David Michael Director   –       •      –    2023-11-10 4 B $9.88 $167,943 D/D 17,000 144,389 2.39     -
   Brownstein Carrie Chief Medical Officer   •       –      –    2023-10-04 4 AS $19.43 $207,298 D/D (10,628) 105,685     -
   Bunker Kevin D. Chief Scientific Officer   •       –      –    2023-10-04 4 AS $19.43 $118,355 D/D (6,068) 859,089     -
   Epperly Melissa B, Chief Financial Officer   •       –      –    2023-10-04 4 AS $19.43 $106,926 D/D (5,482) 387,691     -
  240 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us